IL6 and breast cancer: In addition, TNF-α, IL-6, PCT, and PTX-3 levels were found statistically significant in colon cancer patients compared to breast cancer patients (for all p<0.001) Table 2 and Table 3 summarize the clinicopathological features of breast cancer and colon cancer patients, respectively.